You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 285 No. 11, March 21, 2001 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Toward Optimal Laboratory Use
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (259)
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Oncology
 •Cervical Cancer
 •Pathology & Laboratory Medicine
 •Statistics and Research Methods
 •Alert me on articles by topic

Interobserver Reproducibility of Cervical Cytologic and Histologic Interpretations

Realistic Estimates From the ASCUS-LSIL Triage Study

Mark H. Stoler, MD; Mark Schiffman, MD,MPH; for the Atypical Squamous Cells of Undetermined Significance–Low-grade Squamous Intraepithelial Lesion Triage Study (ALTS) Group

JAMA. 2001;285:1500-1505.

Context  Despite a critical presumption of reliability, standards of interpathologist agreement have not been well defined for interpretation of cervical pathology specimens.

Objective  To determine the reproducibility of cytologic, colposcopic histologic, and loop electrosurgical excision procedure (LEEP) histologic cervical specimen interpretations among multiple well-trained observers.

Design and Setting  The Atypical Squamous Cells of Undetermined Significance–Low-grade Squamous Intraepithelial Lesion (ASCUS-LSIL) Triage Study (ALTS), an ongoing US multicenter clinical trial.

Subjects  From women enrolled in ALTS during 1996-1998, 4948 monolayer cytologic slides, 2237 colposcopic biopsies, and 535 LEEP specimens were interpreted by 7 clinical center and 4 Pathology Quality Control Group (QC) pathologists.

Main Outcome Measures  {kappa} Values calculated for comparison of the original clinical center interpretation and the first QC reviewer's masked interpretation of specimens.

Results  For all 3 specimen types, the clinical center pathologists rendered significantly more severe interpretations than did reviewing QC pathologists. The reproducibility of monolayer cytologic interpretations was moderate ({kappa} = 0.46; 95% confidence interval [CI], 0.44-0.48) and equivalent to the reproducibility of punch biopsy histopathologic interpretations ({kappa} = 0.46; 95% CI, 0.43-0.49) and LEEP histopathologic interpretations ({kappa} = 0.49; 95% CI, 0.44-0.55). The lack of reproducibility of histopathology was most evident for less severe interpretations.

Conclusions  Interpretive variability is substantial for all types of cervical specimens. Histopathology of cervical biopsies is not more reproducible than monolayer cytology, and even the interpretation of LEEP results is variable. Given the degree of irreproducibility that exists among well-trained pathologists, realistic performance expectations should guide use of their interpretations.


Author Affiliations: University of Virginia Health System, Charlottesville (Dr Stoler); and National Cancer Institute, Bethesda, Md (Dr Schiffman).


RELATED LETTERS

Interobserver Agreement About Cervical Cytologic and Histologic Diagnosis
David A. Mulkey, Mark H. Stoler, and Mark Schiffman
JAMA. 2001;285(22):2855-2856.
EXTRACT | FULL TEXT  

Benefits and Costs of Using HPV Testing to Screen for Cervical Cancer
Jeanne S. Mandelblatt, William F. Lawrence, Sharita Mizell Womack, Denise Jacobson, Bin Yi, Yi-ting Hwang, Karen Gold, James Barter, and Keerti Shah
JAMA. 2002;287(18):2372-2381.
ABSTRACT | FULL TEXT  

RELATED ARTICLE

Implications of Low Diagnostic Reproducibility of Cervical Cytologic and Histologic Diagnoses
Suzanne M. Selvaggi
JAMA. 2001;285(11):1506-1508.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Descriptive Evidence That Risk Profiles for Cervical Intraepithelial Neoplasia 1, 2, and 3 Are Unique
Belinson et al.
Cancer Epidemiol. Biomarkers Prev. 2008;17:2350-2355.
ABSTRACT | FULL TEXT  

Persistent Human Papillomavirus Infection and Cervical Neoplasia: A Systematic Review and Meta-Analysis
Koshiol et al.
Am J Epidemiol 2008;168:123-137.
ABSTRACT | FULL TEXT  

A Comparison of Linear Array and Hybrid Capture 2 for Detection of Carcinogenic Human Papillomavirus and Cervical Precancer in ASCUS-LSIL Triage Study
Gravitt et al.
Cancer Epidemiol. Biomarkers Prev. 2008;17:1248-1254.
ABSTRACT | FULL TEXT  

High-risk human papillomavirus is present in cytologically false-negative smears: an analysis of "normal" smears preceding CIN2/3
Bulk et al.
J. Clin. Pathol. 2008;61:385-389.
ABSTRACT | FULL TEXT  

Interobserver Agreement in the Evaluation of Digitized Cervical Images
Jeronimo et al.
Obstet Gynecol 2007;110:833-840.
ABSTRACT | FULL TEXT  

Risk of Precancer and Follow-up Management Strategies for Women With Human Papillomavirus-Negative Atypical Squamous Cells of Undetermined Significance
Safaeian et al.
Obstet Gynecol 2007;109:1325-1331.
ABSTRACT | FULL TEXT  

Reproducibility and reliability of the ankle--brachial index as assessed by vascular experts, family physicians and nurses
Holland-Letz et al.
Vasc Med 2007;12:105-112.
ABSTRACT  

Our approach to squamous intraepithelial lesions of the uterine cervix
Kalof and Cooper
J. Clin. Pathol. 2007;60:449-455.
FULL TEXT  

Mouthwash as a Low-Cost and Safe Specimen Transport Medium for Human Papillomavirus DNA Testing of Cervicovaginal Specimens
Castle et al.
Cancer Epidemiol. Biomarkers Prev. 2007;16:840-843.
ABSTRACT | FULL TEXT  

American Cancer Society Guideline for Human Papillomavirus (HPV) Vaccine Use to Prevent Cervical Cancer and Its Precursors
Saslow et al.
CA Cancer J Clin 2007;57:7-28.
ABSTRACT | FULL TEXT  

Dynamic behavioural interpretation of cervical intraepithelial neoplasia with molecular biomarkers
Baak et al.
J. Clin. Pathol. 2006;59:1017-1028.
ABSTRACT | FULL TEXT  

Smokers at higher risk for undetected antibody for oncogenic human papillomavirus type 16 infection.
Wiley et al.
Cancer Epidemiol. Biomarkers Prev. 2006;15:915-920.
ABSTRACT | FULL TEXT  

Human papillomavirus triage for young women with atypical squamous cells of undetermined significance.
Wright et al.
Obstet Gynecol 2006;107:822-829.
ABSTRACT | FULL TEXT  

Incident High-Grade Squamous Intraepithelial Lesions in Senegalese Women With and Without Human Immunodeficiency Virus Type 1 (HIV-1) and HIV-2
Hawes et al.
JNCI J Natl Cancer Inst 2006;98:100-109.
ABSTRACT | FULL TEXT  

A 21-Year-Old Woman With Atypical Squamous Cells of Undetermined Significance
Sawaya
JAMA 2005;294:2210-2218.
FULL TEXT  

The Elevated 10-Year Risk of Cervical Precancer and Cancer in Women With Human Papillomavirus (HPV) Type 16 or 18 and the Possible Utility of Type-Specific HPV Testing in Clinical Practice
Khan et al.
JNCI J Natl Cancer Inst 2005;97:1072-1079.
ABSTRACT | FULL TEXT  

Spontaneous Regression of High-Grade Cervical Dysplasia: Effects of Human Papillomavirus Type and HLA Phenotype
Trimble et al.
Clin. Cancer Res. 2005;11:4717-4723.
ABSTRACT | FULL TEXT  

Diagnostic accuracy of self collected vaginal specimens for human papillomavirus compared to clinician collected human papillomavirus specimens: a meta-analysis
Ogilvie et al.
Sex. Transm. Infect. 2005;81:207-212.
ABSTRACT | FULL TEXT  

Smoking Is a Risk Factor for Cervical Intraepithelial Neoplasia Grade 3 among Oncogenic Human Papillomavirus DNA-Positive Women with Equivocal or Mildly Abnormal Cytology
McIntyre-Seltman et al.
Cancer Epidemiol. Biomarkers Prev. 2005;14:1165-1170.
ABSTRACT | FULL TEXT  

Comparison of Human Papillomavirus Messenger RNA and DNA Detection: A Cross-sectional Study of 4,136 Women >30 Years of Age with a 2-Year Follow-up of High-Grade Squamous Intraepithelial Lesion
Molden et al.
Cancer Epidemiol. Biomarkers Prev. 2005;14:367-372.
ABSTRACT | FULL TEXT  

The Effect of Loop Electrosurgical Excision Procedure on Future Pregnancy Outcome
Samson et al.
Obstet Gynecol 2005;105:325-332.
ABSTRACT | FULL TEXT  

Patient-clinician agreement on signs and symptoms of 'strep throat': a MetroNet study
Xu et al.
Fam Pract 2004;21:599-604.
ABSTRACT | FULL TEXT  

Validation of p16INK4a as a Marker of Oncogenic Human Papillomavirus Infection in Cervical Biopsies from a Population-Based Cohort in Costa Rica
Wang et al.
Cancer Epidemiol. Biomarkers Prev. 2004;13:1355-1360.
ABSTRACT | FULL TEXT  

Highly Active Antiretroviral Therapy and Cervical Squamous Intraepithelial Lesions in Human Immunodeficiency Virus-Positive Women
Ahdieh-Grant et al.
JNCI J Natl Cancer Inst 2004;96:1070-1076.
ABSTRACT | FULL TEXT  

Predictive Significance of the Alterations of p16INK4A, p14ARF, p53, and Proliferating Cell Nuclear Antigen Expression in the Progression of Cervical Cancer
Wang et al.
Clin. Cancer Res. 2004;10:2407-2414.
ABSTRACT | FULL TEXT  

Have We Resolved How To Triage Equivocal Cervical Cytology?
Solomon and Schiffman
JNCI J Natl Cancer Inst 2004;96:250-251.
FULL TEXT  

Virologic Versus Cytologic Triage of Women With Equivocal Pap Smears: A Meta-analysis of the Accuracy To Detect High-Grade Intraepithelial Neoplasia
Arbyn et al.
JNCI J Natl Cancer Inst 2004;96:280-293.
ABSTRACT | FULL TEXT  

ZYC101a for Treatment of High-Grade Cervical Intraepithelial Neoplasia: A Randomized Controlled Trial
Garcia et al.
Obstet Gynecol 2004;103:317-326.
ABSTRACT | FULL TEXT  

Risk of Cervical Cancer Associated with Extending the Interval between Cervical-Cancer Screenings
Sawaya et al.
NEJM 2003;349:1501-1509.
ABSTRACT | FULL TEXT  

Determinants of Human Papillomavirus Load among Women with Histological Cervical Intraepithelial Neoplasia 3: Dominant Impact of Surrounding Low-Grade Lesions
Sherman et al.
Cancer Epidemiol. Biomarkers Prev. 2003;12:1038-1044.
ABSTRACT | FULL TEXT  

Chapter 11: Future Directions in Cervical Pathology
Sherman
J Natl Cancer Inst Monogr 2003;2003:72-79.
ABSTRACT | FULL TEXT  

Chapter 13: Primary Screening of Cervical Cancer With Human Papillomavirus Tests
Franco
J Natl Cancer Inst Monogr 2003;2003:89-96.
ABSTRACT | FULL TEXT  

Chapter 14: Role of Triage Testing in Cervical Cancer Screening
Solomon
J Natl Cancer Inst Monogr 2003;2003:97-101.
ABSTRACT | FULL TEXT  

Chapter 18: Statistical Issues in the Design and Analysis of Studies of Human Papillomavirus and Cervical Neoplasia
Wacholder
J Natl Cancer Inst Monogr 2003;2003:125-130.
ABSTRACT | FULL TEXT  

Observer Agreement With Laparoscopic Diagnosis of Pelvic Inflammatory Disease Using Photographs
Molander et al.
Obstet Gynecol 2003;101:875-880.
ABSTRACT | FULL TEXT  

Histopathologic Extent of Cervical Intraepithelial Neoplasia 3 Lesions in the Atypical Squamous Cells of Undetermined Significance Low-grade Squamous Intraepithelial Lesion Triage Study: Implications for Subject Safety and Lead-time Bias
Sherman et al.
Cancer Epidemiol. Biomarkers Prev. 2003;12:372-379.
ABSTRACT | FULL TEXT  

Triage of Atypical Squamous Cells of Undetermined Significance With Hybrid Capture II: Colposcopy and Histologic Human Papillomavirus Correlation
Lonky et al.
Obstet Gynecol 2003;101:481-489.
ABSTRACT | FULL TEXT  

Baseline Cytology, Human Papillomavirus Testing, and Risk for Cervical Neoplasia: A 10-Year Cohort Analysis
Sherman et al.
JNCI J Natl Cancer Inst 2003;95:46-52.
ABSTRACT | FULL TEXT  

Optimizing the Hybrid Capture II Human Papillomavirus Test to Detect Cervical Intraepithelial Neoplasia
Howard et al.
Obstet Gynecol 2002;100:972-980.
ABSTRACT | FULL TEXT  

Evaluation of Human Papillomavirus Testing in Primary Screening for Cervical Abnormalities: Comparison of Sensitivity, Specificity, and Frequency of Referral
Kulasingam et al.
JAMA 2002;288:1749-1757.
ABSTRACT | FULL TEXT  

Costs and Benefits of Different Strategies to Screen for Cervical Cancer in Less-Developed Countries
Mandelblatt et al.
JNCI J Natl Cancer Inst 2002;94:1469-1483.
ABSTRACT | FULL TEXT  

Discrepancy in the Interpretation of Cervical Histology by Gynecologic Pathologists
Parker et al.
Obstet Gynecol 2002;100:277-280.
ABSTRACT | FULL TEXT  

Benefits and Costs of Using HPV Testing to Screen for Cervical Cancer
Mandelblatt et al.
JAMA 2002;287:2372-2381.
ABSTRACT | FULL TEXT  

2001 Consensus Guidelines for the Management of Women With Cervical Cytological Abnormalities
Wright et al.
JAMA 2002;287:2120-2129.
ABSTRACT | FULL TEXT  

New Bethesda Terminology and Evidence-Based Management Guidelines for Cervical Cytology Findings
Stoler
JAMA 2002;287:2140-2141.
FULL TEXT  

ASCUS LSIL Triage Study (ALTS) Conclusions Reaffirmed: Response to a November 2001 Commentary
Solomon et al.
Obstet Gynecol 2002;99:671-674.
FULL TEXT  

Results of Human Papillomavirus DNA Testing with the Hybrid Capture 2 Assay Are Reproducible
Castle et al.
J. Clin. Microbiol. 2002;40:1088-1090.
ABSTRACT | FULL TEXT  

The Management of ASCUS Cervical Cytologic Abnormalities and HPV Testing: A Cautionary Note
Herbst et al.
Obstet Gynecol 2001;98:849-851.
ABSTRACT | FULL TEXT  

Interobserver Agreement About Cervical Cytologic and Histologic Diagnosis
Mulkey et al.
JAMA 2001;285:2855-2856.
FULL TEXT  

Implications of Low Diagnostic Reproducibility of Cervical Cytologic and Histologic Diagnoses
Selvaggi
JAMA 2001;285:1506-1508.
FULL TEXT  

Women's Health--Filling the Gaps
DeAngelis and Winker
JAMA 2001;285:1508-1509.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.